Recently Viewed

News Announcement

Lincoln Pharmaceuticals: Corporate Action-Board approves Dividend

28-May-2026 Follow Value Research Online on Google download pdfDownload PDF Lincoln Pharma

Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity share of face value Rs. 10/- each for the financial year ended March 31 2026 subject to approval of the members at the ensuing Annual General Meeting of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan